Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Front Cell Infect Microbiol ; 11: 622899, 2021.
Article de Anglais | MEDLINE | ID: mdl-33796477

RÉSUMÉ

The earliest interaction between macrophages and Paracoccidioides brasiliensis is particularly important in paracoccidioidomycosis (PCM) progression, and surface proteins play a central role in this process. The present study investigated the contribution of ß2 integrin in P. brasiliensis-macrophage interaction and PCM progression. We infected ß2-low expression (CD18low) and wild type (WT) mice with P. brasiliensis 18. Disease progression was evaluated for fungal burden, lung granulomatous lesions, nitrate levels, and serum antibody production. Besides, the in vitro capacity of macrophages to internalize and kill fungal yeasts was investigated. Our results revealed that CD18low mice infected with Pb18 survived during the time analyzed; their lungs showed fewer granulomas, a lower fungal load, lower levels of nitrate, and production of high levels of IgG1 in comparison to WT animals. Our results revealed that in vitro macrophages from CD18low mice slowly internalized yeast cells, showing a lower fungal burden compared to WT cells. The migration capacity of macrophages was compromised and showed a higher intensity in the lysosome signal when compared with WT mice. Our data suggest that ß2 integrins play an important role in fungal survival inside macrophages, and once phagocytosed, the macrophage may serve as a protective environment for P. brasiliensis.


Sujet(s)
Paracoccidioides , Blastomycose sud-américaine , Animaux , Antigènes CD18 , Poumon , Macrophages , Souris
2.
Med Mycol ; 54(2): 177-88, 2016 Feb.
Article de Anglais | MEDLINE | ID: mdl-26384386

RÉSUMÉ

Paracoccidioidomycosis (PCM) is a systemic mycosis, widespread in Latin America. PCM is a granulomatous disease characterized by a polymorphism of lesions depending on the pathogen's virulence, the immune status of the host and its genetic susceptibility. The thermodimorphic fungus Paracoccidioides brasiliensis was considered the only etiologic agent of PCM, yet recent works have shown significant genetic diversity among different strains of P. brasiliensis. Therefore, it has been proposed for a new species within the Paracoccidioides genus, named Paracoccidioides lutzii. To better understand the fungus-host interactions elicited by strains Pb01 and Pb18 as key representatives of P. lutzii and P. brasiliensis, respectively, we carried out studies to investigate differences in morphology, induced immune response, virulence and pathology between these two Paracoccidioides species. Our results demonstrate distinct patterns of host-parasite interaction and pathology caused by Pb18 and Pb01. These results open up new fronts for NEW: clinical studies, which may result in significant consequences for the diagnosis and treatment of PCM. Considering that our results cannot be extended to all strains of both species, more studies about the virulence among Paracoccioides must be explored in the future.


Sujet(s)
Interactions hôte-pathogène , Paracoccidioides/cytologie , Paracoccidioides/immunologie , Blastomycose sud-américaine/microbiologie , Blastomycose sud-américaine/anatomopathologie , Animaux , Modèles animaux de maladie humaine , Mâle , Souris de lignée BALB C , Paracoccidioides/pathogénicité , Blastomycose sud-américaine/immunologie , Virulence
3.
Virus Res ; 176(1-2): 119-27, 2013 Sep.
Article de Anglais | MEDLINE | ID: mdl-23747526

RÉSUMÉ

Baculoviruses are highly specific and only capable of replication in arthropod hosts. The Autographa californica multiple nucleopolyhedrovirus (AcMNPV) is the most studied baculovirus at the molecular level and the Anticarsia gemnatalis multiple nucleopolyhedrovirus (AgMNPV) is the most used viral insecticide worldwide. AcMNPV have also been shown to stimulate the mammalian immune response acting as an adjuvant. In order to evaluate the effects of AgMNPV in modulating macrophage and lymphocyte activation, we have stimulated these cells in vitro and inoculated BALB/c mice intranasally with the two viral phenotypes (PIBs and BVs) and compared with the response induced by the same phenotypes of AcMNPV. Our results showed that baculoviruses are able to modulate mammalian immune response; in vitro they increase phagocytosis, NO2 production and Th1 cells response. In vivo, AgMNPV BVs or PIBs do not induce an inflammatory reaction in normal lung but during a fungal lung infection they can change the type of adaptive response developed. Considering our data, AgMNPV can be considered more useful as a vaccine vector or immune adjuvant than AcMNPV.


Sujet(s)
Lymphocytes/immunologie , Macrophages/immunologie , Nucleopolyhedrovirus/immunologie , Animaux , Cytokines/métabolisme , Activation des lymphocytes , Lymphocytes/virologie , Activation des macrophages , Macrophages/virologie , Souris , Souris de lignée BALB C , Monoxyde d'azote/métabolisme , Phagocytose
4.
Mycopathologia ; 175(5-6): 463-75, 2013 Jun.
Article de Anglais | MEDLINE | ID: mdl-23179449

RÉSUMÉ

Chromoblastomycosis (CBM) is a chronic subcutaneous mycosis, caused by several dimorphic, pigmented dematiaceous fungi. Patients with the disease are still considered a therapeutic challenge, mainly due to its recalcitrant nature. There is no "gold standard" treatment for this neglected mycosis, but rather there are several treatment options. Chemotherapy alternatives include 5-flucytosine, itraconazole, terbinafine, fluconazole, thiabendazole, ketoconazole and amphotericin B, although the healing of severe cases is still uncommon. However, several studies have reported the DNA vaccine to be promising in the treatment for fungal infections; this vaccine allows the host to restore depressed cellular immunity, minimizing the toxic effects from conventional antifungal therapies. This work was therefore carried out aiming to establish a suitable model for experimental CBM, suggesting also new therapies, including DNA-hsp65 vaccine. By analyzing the morphometrical and histopathological aspects and by quantifying the fungal burden, the results showed the establishment of a chronic, although transitory, experimental CBM model with lesions similar to those presented in humans. A treatment regimen using intralesional itraconazole or amphotericin B was effective in treating experimental CBM, as was a therapy using naked DNA-hsp65 vaccine. It has also been shown that chemotherapy associated with DNA-hsp65 vaccine is promising in the treatment for CBM.


Sujet(s)
Protéines bactériennes/immunologie , Chaperonine-60/immunologie , Chromoblastomycose/thérapie , Facteurs immunologiques/administration et posologie , Vaccins à ADN/administration et posologie , Animaux , Antifongiques/usage thérapeutique , Protéines bactériennes/génétique , Chaperonine-60/génétique , Chromoblastomycose/microbiologie , Chromoblastomycose/anatomopathologie , Numération de colonies microbiennes , Modèles animaux de maladie humaine , Histocytochimie , Facteurs immunologiques/génétique , Mâle , Rat Wistar , Résultat thérapeutique , Vaccins à ADN/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE